Renin as a Biomarker of Haemodynamic Normalisation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

104 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-24

Study Completion Date

2021-03-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study design Observational, single centre, prospective cohort study Planned sample size 100 participants

Inclusion criteria The study will evaluate a cohort of participants meeting the following inclusion criteria:

1. admission to the Intensive Care Unit (ICU) after elective and emergency cardiac surgery using cardiopulmonary bypass
2. age 18 years and above
3. arterial, central venous and pulmonary arterial catheters have been inserted as part of routine care Study procedures In addition to routine clinical postoperative data and blood collection, serum renin levels will be analysed on admission, 6 and 24 hours after admission to ICU Study duration 6 months

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Laboratory Outcome Predictors in Coronary Surgery

NCT01178866

Left Ventricular Dysfunction Coronary Artery Bypass Surgery Tissue Hypoperfusion

COMPLETED

Biomarkers Correlation With Volemia

NCT01858675

Cerebral Hemorrhage Head Injury Non Traumatic Post Surgery +2 more

COMPLETED NA

Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%)

NCT01673230

Ventricular Dysfunction

COMPLETED NA

Perioperative Cardiac Troponin Levels in Healthy Adults

NCT02394288

Extremity Orthopedic Surgery

COMPLETED

Hemodilution and Outcome in Cardiac Surgery

NCT00364494

Kidney Failure Intraoperative Complications

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The renin-angiotensin aldosterone system (RAAS) is integral to cardiovascular homeostasis and involved in the regulation of blood pressure, electrolyte balance and intravascular volume. Renin is produced from the renal juxtaglomerular cells and converts angiotensinogen to angiotensin. Angiotensin is subsequently converted to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II also promotes the release of aldosterone.The RAAS has an important role in hypotension to retain water through aldosterone and increase systemic vascular resistance mainly through angiotensin II but also through the release of vasopressin.

The RAAS can become dysregulated in critically ill shocked patients. In states such as septic shock the effects of the RAAS are antagonized through the production of vasodilators such a nitric oxide and both angiotensin I and angiotensin II receptors are down regulated. Activation of angiotensin I receptors may furthermore result in the production of pro-inflammatory cytokines that results in further vasodilation and contributes to cardiovascular compromise.

While the RAAS has been extensively investigated in cardiovascular patients there is a paucity of studies relevant to ICU. A recent study suggested that raised serum renin levels in patients with sepsis is associated with acute renal failure. Another study of a small heterogeneous cohort of critically ill patients compared renin to lactate as marker of tissue perfusion.

As RAAS is closely related to the volume state, there is a physiological rationale to investigate serum renin levels together with variables to monitor the intravascular volume, including assessment of the mean systemic filling pressure (Pmsf). An analogue of the Pmsf will be calculated in this study based on routine postoperative haemodynamic monitoring (mean arterial pressure, MAP, central venous pressure, CVP, cardiac output, CO).

Furthermore, there is no current research which looks at serum renin as marker of hemodynamic normalization or association with outcomes after cardiac surgery which is the main purpose of this study.

Serum renin as a candidate sensitive biomarker of hemodynamic homeostasis will be compared to current clinical markers of resuscitation and perfusion including cardiac index, mixed venous oxygen saturation, lactate and venoarterial carbon dioxide gradients.

If the serum renin concentration is found to be a marker of resuscitation and hemodynamic status, the study will examine any associations with lack of hemodynamic normalization and morbidity in cardiothoracic patients. A pragmatic, composite morbidity outcome at 30 days will be used as the primary endpoint. This includes renal impairment, myocardial infarction, persistent cardiogenic shock, arrythmia, respiratory failure, delirium and stroke. An exploratory, secondary outcome will focus on whether serum renin concentrations are associated with acute kidney injury and the need of renal replacement therapy in post cardiac surgical patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

The study will evaluate a cohort of participants meeting the following inclusion criteria:

1. Admission to ICU after elective and emergency cardiac surgery following cardiopulmonary bypass
2. Age 18 years and above
3. Arterial, central venous and pulmonary arterial catheters have been inserted as part of routine care

Data collection, serum renin among routine blood collection on admission, 6 and 24 hours after admission to ICU

blood sampling

Intervention Type DIAGNOSTIC_TEST

sampling serum renin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

blood sampling

sampling serum renin

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Admission to ICU after elective and emergency cardiac surgery following cardiopulmonary bypass
2. Age 18 years and above
3. Arterial, central venous catheters and pulmonary arterial catheters are inserted preoperatively

Exclusion Criteria

1. Age under 18 years
2. Known pregnancy
3. Arterial, central venous catheters and pulmonary arterial catheters that are not indicated as part of routine care
4. End stage renal disease requiring renal replacement therapy
5. Participants with known Child Pugh A cirrhosis or greater
6. Treatment with any steroids
7. Participant is not expected to live beyond the day after the day of admission

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No